Social Media Ideas for Abbott Laboratories

Abbott raises 2026 profit forecast on strength in diagnostics, heart devices

Abbott pens blood-based Alzheimer's testing pact with ALZpath

Abbott has become the latest company to team up with Alzheimer’s disease blood test developer ALZpath.

Abbott Laboratories: Double Beat And Raise Surprises The Street (Rating Upgrade)

Abbott: Associate Sales Representative, CRM (New Braunfels, TX)

Headquarters: United States of America : Remote URL: http://abbott.com Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portf...

Abbott: Clinical Specialist, CRM (Denver, CO)

Headquarters: United States of America : Remote URL: http://abbott.com Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portf...

Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026?

Abbott trades at a fraction of Glaukos' valuation, but one company burns cash while the other generates billions.

Abbott: Sr. Clinical Specialist, CRM - St Petersburg, FL

Headquarters: United States of America : Remote URL: http://abbott.com Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portf...

In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000

Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot.

<![CDATA[Eli Lilly and Abbisko Announce Drug Development Collaboration]]>

<![CDATA[AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration]]>

<![CDATA[Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion]]>

AbbVie Oncology

AbbVie Oncology Anonymous (not verified) Fri, 07/10/2026 - 09:11 field_thread_url https://cafepharma.com/boards/threads/abbvie-oncology.699564/...

AbbVie Oncology

AbbVie Oncology Anonymous (not verified) Fri, 07/03/2026 - 06:06 field_thread_url https://cafepharma.com/boards/threads/abbvie-oncology.699564/...

AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs

AbbVie’s largest deal in more than half a decade adds a group of immune disease medications — among them a Dupixent competitor — the company believes to have “mega-blockbuster” sal...

DOJ dropped Abbott baby formula criminal probe despite pile of evidence: WSJ

AbbVie to Acquire Apogee Therapeutics for $10.9B

Apogee’s lead candidate zumilokibart, an IL-13 inhibitor also called APG777, is a long-acting treatment that, according to the company, holds “pipeline-in-a-product potential” beca...

Freenome colorectal cancer test data improve on earlier results

The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analy...

Is AbbVie a Buy After Its Purchase of Apogee?

The pharmaceutical company gains a prospective blockbuster with the deal, but is it worth $10.9 billion?

May 28 2026 - AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer

May 28 2026 - AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer admin Thu, 05/28/2026 - 11:51 Steady progress across the board today, with new appro...

Two Paths to Growth: Johnson & Johnson vs AbbVie

DOJ Closes Criminal Probe Into Abbott Over Baby Formula Plant, WSJ Reports

The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula plant linked to potentially deadly bacteria and infant deaths, opti...

Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom

Don't sleep on these medical device leaders.

Eli Lilly reunites with Abbisko in $1.9B, multiple target R&D pact

Eli Lilly has expanded its relationship with Abbisko Therapeutics, committing up to $1.9 billion to get the Chinese biotech to apply its drug discovery and early development capabi...